Renflexis approved as second infliximab biosimilarApril 21, 2017Ankylosing spondylitisRheumatoid ArthritisPsoriatic Arthritis
Compounding rules challenge practice normsApril 10, 2017OsteoarthritisLupus & Connective Tissue DiseasesGoutAnkylosing spondylitisRheumatoid ArthritisSpondyloarthropathiesPsoriatic Arthritis
Secukinumab beat etanercept in 52-week psoriasis quality of life analysisApril 9, 2017Psoriatic Arthritis
Shingles vaccine deemed effective in people with autoimmune diseaseMarch 21, 2017Rheumatoid ArthritisAnkylosing spondylitisPsoriatic ArthritisSpondyloarthropathies
Adalimumab for psoriasis: Blocking TNF-alpha had no effect on vascular inflammationMarch 15, 2017Psoriatic Arthritis
CDC: Greater activity limitations accompany rising arthritis prevalenceMarch 7, 2017OsteoarthritisRheumatoid ArthritisLupus & Connective Tissue DiseasesGoutPsoriatic Arthritis
Biosimilars: No big dollar savings, but are clinically ‘dead on’March 7, 2017Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitisBusiness of Medicine
